3043U |
Metoprolol, Urine |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3063U |
Mycophenolic Acid and Metabolite, Urine |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3082U |
Molindone, Urine |
3090U |
Molybdenum, Urine |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3099U |
Phthalates Panel, Urine |
3103U |
Nadolol, Urine |
3111U |
Naloxone - Total (Conjugated/Unconjugated), Urine |
3113U |
Naloxone - Total (Conjugated/Unconjugated) Screen, Urine |
3116U |
Naltrexone and Metabolite - Total (Conjugated/Unconjugated), Urine |
3140U |
Nickel, Urine |
3145U |
Nefazodone, Urine |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3227U |
Beta-Blockers Panel, Urine |
3248U |
Orphenadrine, Urine |
3310U |
Paraldehyde and Metabolite, Urine |
3432U |
Perchloroethylene Exposure, Urine |
3510U |
Phenacetin and Metabolite, Urine |
3525U |
Phenazopyridine, Urine |
3532U |
Phencyclidine Screen, Urine |
3621U |
Phenol Exposure, Urine |
3690U |
Phentermine, Urine |
3957U |
Procyclidine, Urine |
3970U |
Promethazine, Urine |
3975U |
Propanol, n-, Urine |